Fareston is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Kyowa Kirin, Inc,. The primary component is Toremifene Citrate.
Product ID | 42747-327_6ff72243-bef4-4ce1-a51d-7912e637860c |
NDC | 42747-327 |
Product Type | Human Prescription Drug |
Proprietary Name | Fareston |
Generic Name | Toremifene Citrate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1997-06-30 |
Marketing Category | NDA / NDA |
Application Number | NDA020497 |
Labeler Name | KYOWA KIRIN, INC, |
Substance Name | TOREMIFENE CITRATE |
Active Ingredient Strength | 60 mg/1 |
Pharm Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1997-06-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020497 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1997-06-30 |
Marketing Category | NDA |
Application Number | NDA020497 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1997-06-30 |
Marketing End Date | 2016-10-27 |
Marketing Category | NDA |
Application Number | NDA020497 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1997-06-30 |
Ingredient | Strength |
---|---|
TOREMIFENE CITRATE | 60 mg/1 |
SPL SET ID: | 2cab8dd1-3a10-48e6-86ce-0e5275ed49e5 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
42747-327 | Fareston | toremifene citrate |
64980-404 | Toremifene Citrate | Toremifene Citrate |
69539-152 | toremifene citrate | toremifene citrate |
72205-050 | toremifene citrate | toremifene citrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FARESTON 73575128 1460565 Live/Registered |
FARMOS-YHTYMA OY (FARMOS GROUP LTD.) 1985-12-24 |